Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
06/28/18 4 Lederman Seth 2
06/27/18 4 Mario Ernest 2
06/19/18 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Related Documents
9
06/15/18 4 Sullivan Gregory M 2
06/14/18 4 Lederman Seth 2
06/14/18 4 Saenger Bradley 2
06/14/18 4 Morris Jessica Edgar 2
06/13/18 4 Grace Patrick P 1
06/13/18 4 Grange David L 1
06/13/18 4 Landry Donald W 1